O

Olema Oncology

Clinical-stage biopharma targeting ER-positive breast cancer

Senior Director - Commercial Manufacturing and Operations

Supply Chain ManagementConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USAIn-person

About the Job

Requirements

  • A BS, MS, or PhD in Chemistry, Chemical Engineering, Pharmacy, or a related scientific discipline with 15+ years in pharmaceutical CMC, manufacturing, or commercial supply; alternatively, a business degree with 15+ years of relevant CMC or manufacturing leadership experience.
  • Demonstrated small-molecule commercial launch experience, including registrational readiness, process performance qualification (PPQ), process validation, and transition from late-stage development to commercial supply; US launch experience is strongly preferred.
  • Extensive experience governing contract development and manufacturing organizations (CDMOs) across drug substance (DS) and drug product (DP), including technology transfer oversight, performance management, issue escalation, supply and quality agreements, and negotiating commercial supply agreements.
  • Hands-on commercial supply chain experience in supply planning and sales and operations planning (S&OP), inventory management, third-party logistics (3PL) and specialty distribution, and DSCSA serialization.
  • Strong understanding of US and global regulatory requirements for the manufacture, testing, release, and control of commercial small-molecule products.
  • Track record of presenting recommendations, risks, and mitigation scenarios to executive management and influencing internal teams and external partners through communication and negotiation.
  • Leadership experience.

Responsibilities

  • Set the commercial supply strategy for palazestrant, including network design, capacity and second-source planning, and launch inventory build, including at-risk manufacturing and packaging decisions.
  • Own the commercial supply budget, cost of goods sold (COGS) inputs, supply cost key performance indicators (KPIs), and tariff exposure in partnership with Finance.
  • Lead supply-side launch readiness from new drug application (NDA) submission through Prescription Drug User Fee Act (PDUFA) action and market entry; maintain the launch risk register and present status, risks, and mitigation options to executive leadership.
  • Provide business and operational oversight of commercial DS and DP manufacturing, partnering with CMC Technical, Quality, and Regulatory on registrational readiness, PPQ, process validation, and transition to commercial supply.
  • Negotiate and own commercial supply agreements; conduct quarterly business reviews and track performance metrics across DS, DP, packaging, and logistics partners.
  • Manage CDMO production schedules day to day, resolving issues and escalating as needed to protect supply.
  • Oversee commercial packaging and labeling vendors, including artwork readiness, labeling specifications, and batch documentation.
  • Work with IT to ensure serialization, aggregation, and traceability systems are validated, DSCSA-compliant, and integrated with 3PL, specialty distributors, and specialty pharmacy partners.
  • Run the monthly S&OP cycle, translating the commercial forecast into DS, DP, and packaging plans and setting safety stock, coverage, and replenishment policies.
  • Manage commercial inventory hands-on across DS, bulk DP, and finished goods, including replenishment, monthly reconciliation, first-expired, first-out (FEFO) compliance, and batch traceability.
  • Coordinate batch disposition with Quality and release finished goods to the 3PL.
  • Provide uninterrupted supplies to the 3PL, where the commercial team would take over management.
  • Partner with Trade & Distribution as appropriate to support commercial supplies and plans.
  • Ensure commercial manufacturing, packaging, serialization, storage, and distribution comply with cGMP, GDP, DSCSA, and applicable regulatory requirements; support audits, inspections, and regulatory submissions.
  • Build the commercial supply function as Olema scales, including systems, processes, and future planning and logistics roles.

Desired Qualifications

  • US launch experience.

About the Company

Olema Oncology

Clinical-stage biopharma targeting ER-positive breast cancer

Olema Oncology develops targeted therapies for women’s cancers, with a focus on ER-positive, HER2-negative breast cancer. Its lead drug, palazestrant (OP-1250), blocks and degrades the estrogen receptor (CERAN/SERD) to slow tumor growth, and a second program targets epigenetics with a KAT6 inhibitor in preclinical stages. The company is conducting a Phase 3 trial of palazestrant in combination with CDK4/6 inhibitors and has a collaboration with Novartis to test palazestrant with ribociclib and everolimus. Its goal is to bring palazestrant to market and advance the KAT6 program to clinical testing, expanding options for women with breast cancer.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Olema Oncology

See more jobs